Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699757 | Clinical Oncology | 2006 | 8 Pages |
Abstract
EGFR status predicts the local response to radiotherapy but does not provide prognostic utility in relation to overall or bladder cancer-specific survival. As EGFR status seems to be linked to the initial response to radiotherapy, its inhibition may be a means of enhancing the radio-responsiveness of these poor prognosis tumours.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.J. Colquhoun, S. Sundar, P.H. Rajjayabun, T.R.L. Griffiths, R.P. Symonds, J.K. Mellon,